Cipla gets shareholders’ nod to raise Rs 3,000 crore

19 Aug 2019 Evaluate

Cipla has received shareholders’ approval to raise up to Rs 3,000 crore through issuance of equity shares or other securities convertible into equity shares. Earlier, the company's board had approved raising funds up to Rs 3,000 crore.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. The company’s portfolio includes over 1500 products across wide range of therapeutic categories with one quality standard globally.

Cipla Share Price

1223.05 -19.60 (-1.58%)
30-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1757.35
Dr. Reddys Lab 1254.65
Cipla 1223.05
Zydus Lifesciences 871.20
Lupin 2312.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×